Form 4: Boston Scientific EVP Exercises Stock Options and Disposes of Shares
SEC Form 4 Filing
Arthur C. Butcher, EVP & Group President at Boston Scientific, executed stock options and disposed of shares on February 12, 2025.
Summary
- Arthur C. Butcher, an EVP at Boston Scientific, reported transactions involving the company's common stock on February 12, 2025.
- Butcher exercised restricted stock units, acquiring 2,692 shares of common stock at $0.00.
- He also disposed of 950 shares to cover tax obligations at a price of $105.77 per share.
- Following these transactions, Butcher directly owns 17,763 shares and indirectly owns 13,364 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects standard insider trading activity related to stock options and tax obligations.
Future Outlook
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are routine and do not indicate a significant change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of transaction: exercise of restricted stock units and disposal of shares. |
| 02/12/2025 | First date shares of common stock will be issued in installments. |
| 02/12/2028 | Expiration date of restricted stock units. |
| 02/14/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.